MAP3K5 and cardiac hypertrophy: Furthermore, we demonstrated that GALNT4 could directly bind to ASK1, inhibiting the dimerization and phosphorylation of ASK1 and mitigating cardiac hypertrophy by inhibiting the ASK1 axis.